ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
The 37,000-year view: Infections in Eurasia
Two new oral drugs for gonorrhea!
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
Developing systemic & inhaled antibiotics for lung infections
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
What does an antibiotic cost to develop? What is it worth? How to afford it?
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet